rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2009-5-4
|
pubmed:abstractText |
The optimal chemotherapeutic protocol for the treatment of esophageal cancer has not yet been established. This study was performed to identify the differences in toxicity and completion rates of various chemotherapy protocols with that goal in mind.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1867-1071
|
pubmed:author |
pubmed-author:HayabuchiNaofumiN,
pubmed-author:IshiokaChikashiC,
pubmed-author:ItamiJunJ,
pubmed-author:KazumotoTomokoT,
pubmed-author:MakinoMasaokiM,
pubmed-author:NemotoKenjiK,
pubmed-author:OnimaruRikiyaR,
pubmed-author:OnishiHiroshiH,
pubmed-author:SakayauchiToruT,
pubmed-author:SasakiShigeruS,
pubmed-author:SuzukiGenG,
pubmed-author:TamamotoTetsuoT,
pubmed-author:TamamuraHiroyasuH,
pubmed-author:YamadaShogoS,
pubmed-author:YamamotoMichinoriM,
pubmed-author:YonekuraRyujiR
|
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
131-7
|
pubmed:dateRevised |
2010-1-26
|
pubmed:meshHeading |
pubmed-meshheading:19412680-Aged,
pubmed-meshheading:19412680-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19412680-Cisplatin,
pubmed-meshheading:19412680-Combined Modality Therapy,
pubmed-meshheading:19412680-Cyclophosphamide,
pubmed-meshheading:19412680-Esophageal Neoplasms,
pubmed-meshheading:19412680-Female,
pubmed-meshheading:19412680-Fluorouracil,
pubmed-meshheading:19412680-Humans,
pubmed-meshheading:19412680-Male,
pubmed-meshheading:19412680-Middle Aged,
pubmed-meshheading:19412680-Patient Compliance,
pubmed-meshheading:19412680-Radiotherapy Dosage,
pubmed-meshheading:19412680-Statistics, Nonparametric,
pubmed-meshheading:19412680-Survival Rate,
pubmed-meshheading:19412680-Treatment Outcome
|
pubmed:year |
2009
|
pubmed:articleTitle |
Comparison of cisplatin and 5-fluorouracil chemotherapy protocols combined with concurrent radiotherapy for esophageal cancer.
|
pubmed:affiliation |
Department of Radiation Oncology, Tohoku University School of Medicine, Sendai, 980-8574, Japan. sakayauchi-rad@umin.ac.jp
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|